Immunocore Holdings Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	400.02	310.2	249.43	174.36	36.48
Revenue	400.02	310.2	249.43	174.36	36.48
Revenue Growth (YoY)	28.95%	24.37%	43.05%	377.91%	-11.26%
Cost of Revenue	13.86	10.5	7.5	6.4	100.25
Gross Profit	386.15	299.7	241.92	167.96	-63.76
Selling, General & Admin	165.41	155.78	144.5	123.06	110.82
Research & Development	266.09	214.38	157.08	96.61	-
Other Operating Expenses	-19.73	-18.05	0.9	-0.01	0.07
Operating Expenses	411.78	352.11	302.47	219.66	110.9
Operating Income	-25.63	-52.41	-60.55	-51.7	-174.66
Interest Expense	-12.17	-18.84	-5.15	-5.41	-5.57
Interest & Investment Income	16.48	25.62	17.99	3.76	0.07
Currency Exchange Gain (Loss)	2.22	-3.45	-13.18	14.16	0.29
EBT Excluding Unusual Items	-19.1	-49.08	-60.89	-39.2	-179.88
Other Unusual Items	-	-3.85	-	-1.69	-
Pretax Income	-19.1	-52.94	-60.89	-40.88	-179.88
Income Tax Expense	16.41	-1.85	-5.6	11.66	0.15
Net Income	-35.51	-51.09	-55.29	-52.54	-180.03
Net Income to Common	-35.51	-51.09	-55.29	-52.54	-180.03
Shares Outstanding (Basic)	50	50	49	46	42
Shares Outstanding (Diluted)	50	50	49	46	42
Shares Change (YoY)	0.71%	2.25%	6.94%	7.59%	60.19%
EPS (Basic)	-0.71	-1.02	-1.13	-1.15	-4.24
EPS (Diluted)	-0.71	-1.02	-1.13	-1.15	-4.24
Free Cash Flow	-15.05	20.89	-2.49	-51.41	-144.49
Free Cash Flow Per Share	-0.30	0.42	-0.05	-1.13	-3.40
Gross Margin	96.53%	96.61%	96.99%	96.33%	-174.77%
Operating Margin	-6.41%	-16.89%	-24.27%	-29.65%	-478.73%
Profit Margin	-8.88%	-16.47%	-22.17%	-30.14%	-493.45%
Free Cash Flow Margin	-3.76%	6.73%	-1.00%	-29.49%	-396.04%
EBITDA	-22.36	-48.21	-56.46	-46.37	-167.07
EBITDA Margin	-5.59%	-15.54%	-22.63%	-26.59%	-
D&A For EBITDA	3.27	4.2	4.09	5.34	7.59
EBIT	-25.63	-52.41	-60.55	-51.7	-174.66
EBIT Margin	-6.41%	-16.89%	-24.27%	-29.65%	-
Revenue as Reported	400.02	310.2	249.43	174.36	36.48

Updated Feb 25, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q